Federation Des Caisses Desjardins Du Quebec Nymox Pharmaceutical Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 14, 2024	SELL	$0.2 - $1.03 $40,200 - $207,030	-201,000 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$0.19 - $0.49 $28,500 - $73,500	-150,000 Reduced 42.74%	201,000 $38.2 Million
Q1 2023 Aug 14, 2024	SELL	$0.33 - $0.5 $9,834 - $14,900	-29,800 Reduced 7.83%	351,000 $119 Million
Q4 2022 Aug 14, 2024	SELL	$0.28 - $0.74 $11,256 - $29,748	-40,200 Reduced 9.55%	380,800 $123 Million
Q2 2022 Aug 14, 2024	SELL	$0.38 - $1.41 $17,100 - $63,450	-45,000 Reduced 9.66%	421,000 $183 Million
Q1 2022 Aug 14, 2024	BUY	$1.21 - $2.0 $563,860 - $932,000	466,000 New	466,000 $587 Million
Q4 2021 Aug 30, 2024	SELL	$0.95 - $2.1 $19,000 - $42,000	-20,000 Reduced 3.84%	501,000 $651 Million
Q3 2021 Aug 30, 2024	SELL	$1.3 - $2.23 $26,065 - $44,711	-20,050 Reduced 3.71%	521,000 $1.07 Billion
Q2 2021 Aug 30, 2024	BUY	$1.46 - $2.48 $789,933 - $1.34 Million	541,050 New	541,050 $855 Million
Q1 2021 Aug 30, 2024	SELL	$2.22 - $3.39 $55,500 - $84,750	-25,000 Reduced 4.34%	551,050 $1.22 Billion
Q3 2020 Aug 30, 2024	SELL	$2.3 - $3.66 $57,499 - $91,500	-25,000 Reduced 4.16%	576,050 $1.42 Billion
Q2 2020 Aug 30, 2024	SELL	$2.1 - $4.6 $31,500 - $69,000	-15,000 Reduced 2.43%	601,050 $2.13 Billion
Q1 2020 Aug 30, 2024	SELL	$1.69 - $3.88 $59,150 - $135,800	-35,000 Reduced 5.38%	616,050 $1.44 Billion
Q4 2019 Aug 30, 2024	SELL	$1.73 - $2.42 $86,500 - $121,000	-50,000 Reduced 7.13%	651,050 $1.43 Billion
Q3 2019 Aug 30, 2024	BUY	$1.41 - $2.12 $1,410 - $2,120	1,000 Added 0.14%	701,050 $1.28 Billion
Q1 2019 Aug 30, 2024	SELL	$1.57 - $2.71 $37,041 - $63,937	-23,593 Reduced 3.26%	700,050 $1.38 Billion
Q4 2018 Aug 30, 2024	BUY	$1.31 - $2.53 $947,972 - $1.83 Million	723,643 New	723,643 $948 Million
Q1 2018 Aug 30, 2024	SELL	$3.09 - $4.43 $169,950 - $243,649	-55,000 Reduced 6.8%	753,793 $3.19 Billion
Q4 2017 Aug 30, 2024	SELL	$3.29 - $4.06 $133,899 - $165,237	-40,699 Reduced 4.79%	808,793 $2.67 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	849,492	849,492 $3.08 Billion

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account